Log In
Print
BCIQ
Print
Print this Print this
 

BOW-015

  Manage Alerts
Collapse Summary General Information
Company Epirus Biopharmaceuticals Inc.
DescriptionBiosimilar of infliximab, a chimeric mAb against tumor necrosis factor (TNF) alpha
Molecular Target Tumor necrosis factor (TNF) alpha
Mechanism of Action 
Latest Stage of DevelopmentPhase III
IndicationRheumatoid arthritis (RA)
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today